Press Release: STADA is in top 3% on pharma sustainability, Morningstar Sustainalytics assessment confirms
One document
more
Stories about Pharmakologie
MaP Toolbox: Your Hub for Master Protocol Clinical Trials
moreEuropäischer Rechnungshof - European Court of Auditors
Läkemedelsbristen är fortfarande en kronisk huvudvärk för EU
moreEuropäischer Rechnungshof - European Court of Auditors
Lääkepula yhä EU:n päänsärkynä
moreEuropäischer Rechnungshof - European Court of Auditors
Medicine shortages still a chronic headache for the EU
morePM: DHL übernimmt SDS Rx und stärkt damit seine Kompetenzen im Bereich Life Sciences und Healthcare / PR: DHL Agrees to Acquire SDS Rx Expanding Its Life Sciences and Healthcare Capabilities
more
Press release: STADA sees strong sales and earnings growth in H1
One documentmoreTherVacB: Advance Curative Strategy for Chronic Hepatitis B
moreFraunhofer-Institut für Produktionstechnologie IPT
Transforming personalized medicine with AI-driven CAR-T manufacturing: Automated CAR-T cell production platform is ready for production
morePress Release : STADA brings in Henshaw from Biogen to head Specialty as Kim leads Western Europe
One documentmorePress Release: STADA’s continued, resilient growth leads to record earnings in Q1
One documentmore- 3
Key technology for bioprocesses
more
Centor Launches Smart Pill Organizer to Support Medication Adherence
moreSHL Medical opens new US$220 million manufacturing facility in the US to serve growing autoinjector market
moreSGLT2 HYPE: New EU-funded Project Aims to Transform Hypertension Treatment
more- 3
Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market
One documentmore LTS Lohmann Therapie-Systeme AG
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
moreSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues
more
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
moreRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
moreGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
moreStrides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
moreInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
more- 2
SHL Medical announces plans to establish SHL Advantec
more
Event Announcement: VIROFIGHT Hybrid Symposium
One documentmoreRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
more- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
One documentmore - 2
Record financing rounds at the Munich biotech hub
One documentmore Press release: STADA continues strong growth journey in the first half of 2024
One documentmore- 2
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
more
123Next